ADAR1 Capital Management »

Evommune shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Evommune (EVMN) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Evommune

Tip: Access up to 7 years of quarterly data

All positions including Evommune held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Evommune by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.2M 184k 17.12

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Avidity Biosciences Ord (RNA)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Arbutus Biopharma (ABUS)
Zai Lab Adr (ZLAB)
Terns Pharmaceuticals (TERN)
Cytomx Therapeutics (CTMX)
Celldex Therapeutics Com New (CLDX)
Rapt Therapeutics Com New (RAPT)

View all positions for ADAR1 Capital Management

Top funds holding Evommune

EQT Fund Management S.a r.l.
Pivotal bioVenture Partners Investment Advisor
Nan Fung Group Holdings
Rtw Investments
Marshall Wace
Eventide Asset Management
Sectoral Asset Management
Verition Fund Management
Standard Life Aberdeen
Velan Capital Investment Management
Vanguard Group
Octagon Capital Advisors
American Century Companies
Federated Investors
Dr. Jeffrey R. Jay, M.D.

View all funds holding Evommune